Hero Image

5 Medications That May Cause Kidney Disease: What to Know

Some everyday and prescription medicines can unexpectedly stress your kidneys. If you have diabetes, high blood pressure, heart disease, a history of kidney problems, or you’re dehydrated, the risk rises. Below, you’ll find five medications linked to kidney injury, how to spot trouble early, and safer ways to protect your kidney health.

5 medications that may cause kidney disease (or injury)

Not everyone who uses these medicines will have a kidney problem. Risk depends on your dose, how long you take the drug, hydration status, age, other conditions, and whether you’re taking more than one kidney-stressing medicine at the same time.

Talk with your clinician or pharmacist before starting or stopping any medicine, including over-the-counter (OTC) drugs and supplements. They can help you weigh benefits and risks, choose safer options, and set up lab monitoring like serum creatinine and eGFR.

  • NSAIDs (ibuprofen, naproxen, diclofenac) – These pain relievers can constrict blood flow into the kidneys, especially at higher doses or with dehydration, heart failure, or existing chronic kidney disease (CKD). Prefer short courses, the lowest effective dose, and avoid combining multiple NSAIDs. Learn more from the National Kidney Foundation and NIDDK.
  • Proton pump inhibitors (PPIs: omeprazole, esomeprazole, pantoprazole) – Widely used for heartburn and GERD, PPIs have been associated with acute interstitial nephritis (AIN), an immune reaction that can harm the kidneys. Use the lowest effective dose for the shortest time and reassess long-term therapy. See the patient information for omeprazole and discuss AIN warning signs with your clinician.
  • Hospital antibiotics (aminoglycosides like gentamicin; and vancomycin) – These powerful IV antibiotics can be nephrotoxic, particularly with prolonged therapy or high blood levels. In hospitals, clinicians monitor drug levels and kidney labs closely. Read more in MedlinePlus entries for gentamicin and vancomycin.
  • Tenofovir disoproxil fumarate (TDF) – An antiviral used for HIV and hepatitis B that can sometimes affect the kidney’s proximal tubules (rarely causing Fanconi syndrome). Risk rises with some boosted regimens or existing CKD; regular eGFR and urine checks are recommended. See NIH’s HIV info on tenofovir DF.
  • Cancer chemotherapies (notably cisplatin; also ifosfamide) – Cisplatin is effective but can be dose‑limited by nephrotoxicity; vigorous IV hydration and electrolyte monitoring are standard preventive steps. Explore the MedlinePlus page for cisplatin and ask your oncology team about kidney-protective protocols.

Remember: the presence of risk does not mean you can’t use these medicines when they’re truly needed; it means you should use them thoughtfully and with appropriate monitoring.

Warning signs of medicine-related kidney trouble

Kidney injury can be silent at first, which is why lab monitoring matters. When symptoms do occur, they may include:

  • Sudden drop in urination or very dark urine
  • Swelling in the legs, ankles, or around the eyes
  • Unexplained fatigue, nausea, or loss of appetite
  • Back or flank pain
  • Itching or metallic taste
  • High blood pressure that’s hard to control

If you notice these changes, contact your healthcare professional promptly. Learn about acute kidney injury (AKI) from NIDDK.

How to lower your risk

Practical steps you can take today

  • Know your numbers: Ask for baseline and follow‑up serum creatinine and eGFR when starting higher‑risk medicines.
  • Hydrate wisely: Dehydration magnifies risk, especially with NSAIDs and contrast dyes. Aim for steady fluid intake unless your doctor has restricted fluids.
  • Avoid double‑dosing: Don’t combine multiple NSAIDs (e.g., RX plus OTC). Check combo cold/flu products carefully.
  • Use the lowest effective dose, shortest duration: Especially for PPIs and NSAIDs.
  • Ask about alternatives: For pain, consider acetaminophen within recommended limits, topical NSAIDs, or non‑drug therapies (heat, stretching, physical therapy) if appropriate.
  • Keep a complete medication list: Include OTC drugs and supplements; share it at every visit.
  • Flag high‑risk combinations: The “triple whammy” of an NSAID + ACE inhibitor/ARB + diuretic can sharply reduce kidney perfusion—avoid unless specifically directed and monitored.

Treatments and medications: what to know if you have kidney disease

Common therapies used to protect kidney function

  • Blood pressure control (ACE inhibitors/ARBs): Core treatments that reduce proteinuria and slow CKD progression. Learn more from the National Kidney Foundation.
  • SGLT2 inhibitors: Originally for diabetes, now shown to help slow CKD and reduce heart failure risk in many patients. See NKF’s overview of SGLT2 inhibitors in CKD.
  • Diuretics: Help control blood pressure and swelling; dosing and choice depend on kidney function.
  • Statins: Often recommended in CKD to lower cardiovascular risk.
  • Phosphate binders and vitamin D analogs: Manage mineral and bone disorder in advanced CKD. See NKF information on phosphorus.
  • Erythropoiesis‑stimulating agents (ESAs) and iron: Treat anemia associated with CKD; more at NIDDK’s page on anemia in CKD.
  • Metabolic acidosis treatment (e.g., sodium bicarbonate): May help slow CKD in selected patients; dosing individualized.
  • Dialysis or transplant evaluation: For advanced kidney failure; explore options via NIDDK.

About Yorvipath, Padcev, Ingrezza, and Valtoco

These medications are frequently asked about, but they are not treatments for kidney disease. They have specific uses and, in some cases, special considerations if you have reduced kidney function. Always follow your prescriber’s guidance and the official prescribing information.

  • Yorvipath (palopegteriparatide): A parathyroid hormone replacement approved in the EU for chronic hypoparathyroidism; not currently approved in the U.S. Kidney considerations relate to calcium and phosphate balance; close lab monitoring is essential. See the European Medicines Agency page for Yorvipath.
  • Padcev (enfortumab vedotin‑ejfv): A targeted therapy for urothelial (bladder) cancer. Kidney function may influence safety monitoring, and some patients with CKD receive it under oncology supervision. Learn more from the official patient site and discuss dosing with your oncologist.
  • Ingrezza (valbenazine): Used for tardive dyskinesia (involuntary movements). Dose adjustments may be considered with significant renal impairment; see the INGREZZA patient site and talk with your prescriber.
  • Valtoco (diazepam nasal spray): Rescue treatment for seizure clusters. While primarily metabolized by the liver, always review all rescue and maintenance seizure medications for renal dosing and drug‑interaction concerns. See VALTOCO.

If you’re prescribed any of these therapies and also have kidney disease, ask your clinician to confirm whether dosing changes or extra lab monitoring are recommended.

Key takeaways

  • Five medicine groups with kidney risks: NSAIDs, PPIs, certain hospital antibiotics (aminoglycosides/vancomycin), tenofovir DF, and cisplatin.
  • Use the lowest effective dose for the shortest time, avoid risky combinations, and monitor labs—especially if you have CKD, diabetes, heart disease, or are older.
  • Know warning signs and contact your care team early; many problems are reversible when caught fast.
  • For ongoing kidney protection, focus on blood pressure, blood sugar, SGLT2 inhibitors when appropriate, and specialist follow‑up.

For more on protecting your kidneys while using medicines, see NIDDK’s guide on keeping kidneys safe and talk with your healthcare team.